Skip to content
Global Allergy & Airways Patient Platform
  • DiseasesExpand
    • Allergic Fungal Rhinosinusitis (AFRS)
    • Allergies
    • Alpha-1
    • Asthma
    • Atopic Dermatitis
    • Bronchiectasis
    • Chronic Cough
    • Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
    • COPD
    • Eosinophilic Esophagitis (EoE)
    • Pulmonary Hypertension
    • Type 2 Inflammatory Diseases
    • Urticaria
  • AwarenessExpand
    • GAAPP Events & Awareness Campaigns
    • GAAPP Regional Groups
    • Media Center
  • EducationExpand
    • Blog
    • Education Overview
    • GAAPP Academy
    • GAAPP Steroid Stewardship Education & Empowerment
    • Tools
    • Understanding Your Medications Neighborhood
  • AdvocacyExpand
    • Advocacy Overview
    • Government Organizations
    • International Respiratory Coalition
    • Lung Health Resolution
    • Person-Centred Access to Treatment
    • RSV Alliance
    • Speak Up For COPD
  • ResearchExpand
    • Research
    • Clinical and Scientific Advisory Panel
    • Publications and International Guidelines
    • Recruiting Opportunities
    • CAAT
    • CERT
    • IREN
    • CompEx
    • PREM-C9
    • COPD Clinical Trials Education
    • The Asthma Impairment and Risk Questionnaire (AIRQ®)
  • Member OrganizationsExpand
    • Become a Member
    • Knowledge Hub
    • List of Member Organizations
  • Knowledge Hub
Global Allergy & Airways Patient Platform

Asthma Bot User Experience

  • >
  • Asthma Bot User Experience

General Experience

How would you describe your overall experience using the asthma chatbot?(Required)
Was the chatbot easy to interact with?(Required)
Did you feel comfortable using the chatbot to talk about your asthma symptoms?(Required)

Functionality and Usability

Were you able to easily understand the chatbot's responses?(Required)
Did the chatbot respond quickly adn accurately to your questions?(Required)
Were there any features or tools that stood out as especially helpful or unhelpful?(Required)

Content and Relevance

Did the information provided by the chatbot seem accurate and reliable?(Required)
Was the advice or support tailored to your specific needs and situation?(Required)
Did the chatbot help you better understand your asthma or how to manage it?(Required)

Trust and Communication

Did you feel that the chatbot understood your concerns?(Required)
Would you trust the chatbot to give you health advice when your doctor isn't available?(Required)
Did you feel that the chatbot respected your privacy and personal information?(Required)

Emotional Response

How did using the chatbot make you feel overall?(Required)
Did you feel more in control of your asthma after using the chatbot?(Required)

Suggestions and Improvements

Did you encounter any technical issues or bugs while using the chatbot?(Required)

Future Use and Recommendation

Would you use the chatbot again?(Required)
Would you recommend this chatbot to others with asthma?(Required)
I agree that GAAPP (The Global Allergy and Airways Patient Platform) may store my contact details for the purpose of analyzing the chatbot survey and the required follow ups with participants, to the contact matter and establishing a communication channel. By agreeing to send this form I confirm that I have read and understood the GAAPP Privacy Policy and Cookies Policy I can revoke this consent at any time via email by contacting based on the GDPR laws as established by the EU (Regulation (EU) 2016/679).
Do you agree?(Required)

Quick Links

    Learn More

    Donate to GAAPP

    From the Blog

    • World Atopic Eczema Day 2026
      World Atopic Eczema Day 2026
    • Next-Generation Propellants
    • GAAPP Board of Directors Elections 2026
      GAAPP Board of Directors Elections 2026

    Clinical Trials Match

    Note on translations: If you are reading this website in a language other than English, it has been auto-translated to your language, unless otherwise stated at the bottom of each page. If you think the translation is inaccurate, please contact us, and we will be happy to review the translation.

    The GAAPP Logo in all white letters. The globe icon is also in all white.
    Sign Up for the Newsletter >
    • Facebook
    • Twitter
    • LinkedIn
    • Instagram
    • YouTube
    • Threads
    • TikTok
    About GAAPP

    About Us
    Board Members & Executive Team
    GAAPP Corporate Council
    Healthcare Professional Organizations
    Government Organizations
    History and Transparency

    Contact Us

    info@gaapp
    +43 (0) 676 7534200
    Webgasse 43/3D, 1060, Vienna, Austria
    EUROPE

    Legal Links

    Imprint
    GAAPP Policies
    Privacy Policy
    Medical Disclaimer

    Quick Links

    Contact Us
    Become a Member
    Blog
    Media Center
    Membership Portal
    Newsletters

    Donate

    Copyright 2026 | GAAPP - Global Allergy and Airways Patient Platform | Maintained by Pulse Marketing

    Scroll to top
    • Diseases
      • Allergic Fungal Rhinosinusitis (AFRS)
      • Allergies
      • Alpha-1
      • Asthma
      • Atopic Dermatitis
      • Bronchiectasis
      • Chronic Cough
      • Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
      • COPD
      • Eosinophilic Esophagitis (EoE)
      • Pulmonary Hypertension
      • Type 2 Inflammatory Diseases
      • Urticaria
    • Awareness
      • GAAPP Events & Awareness Campaigns
      • GAAPP Regional Groups
      • Media Center
    • Education
      • Blog
      • Education Overview
      • GAAPP Academy
      • GAAPP Steroid Stewardship Education & Empowerment
      • Tools
      • Understanding Your Medications Neighborhood
    • Advocacy
      • Advocacy Overview
      • Government Organizations
      • International Respiratory Coalition
      • Lung Health Resolution
      • Person-Centred Access to Treatment
      • RSV Alliance
      • Speak Up For COPD
    • Research
      • Research
      • Clinical and Scientific Advisory Panel
      • Publications and International Guidelines
      • Recruiting Opportunities
      • CAAT
      • CERT
      • IREN
      • CompEx
      • PREM-C9
      • COPD Clinical Trials Education
      • The Asthma Impairment and Risk Questionnaire (AIRQ®)
    • Member Organizations
      • Become a Member
      • Knowledge Hub
      • List of Member Organizations
    • Knowledge Hub